Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...

Beta-blockers can help treat high blood pressure, but their side effects may hide signs of low blood sugar in people with diabetes.

Background Atrial fibrillation (AF) is a major and increasing burden on health services. This study aimed to evaluate the cost-effectiveness of digoxin versus beta-blockers for heart rate control in ...

Taking prescribed beta blockers during hematopoietic stem cell transplantation may increase mortality risk due to suppression of signals from nerves that promote bone marrow regeneration ...

What is a beta blocker? Churchwell said the drug class slows the heart by inhibiting and binding to beta one and beta two receptors on the heart.

What is a beta blocker? Churchwell said the drug class slows the heart by inhibiting and binding to beta one and beta two receptors on the heart.

Beta blockers may delay Huntington motor onset and slow progression. Promising findings for clinical application.

Beta-blocker use was tied with slower symptom progression in people with early motor-manifest Huntington's disease. In a people with genetically confirmed premanifest Huntington's, beta-blocker ...

A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of Iowa Health Care researchers.

TUESDAY, Nov. 12, 2024 (HealthDay News) -- Beta blockers are go-to meds for many people who've survived a heart attack. However, new Swedish research has found that they might not be needed for heart ...

A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD.

Recent clinical trials highlight the need for more careful consideration of beta-blocker treatment regimen following myocardial infarction.